ArticleOncogene2025

Characterizing the tumor suppressor activity of FLCN in Birt-Hogg-Dubé syndrome cell models through transcriptomic and proteomic analysis.

Rachel-Ann Jones et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.